These results further indicate that Grx2 can control ROS levels through its antioxidant activity, maintaining redox homeostasis, thereby reducing ABC differentiation, decreasing T cell activation, lowering autoantibody production, and modulating the progression of SLE. Here, GLRX2 is linked to systemic lupus erythematosus.